Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy

NCT06369272 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT06369272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06369272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Assess Maternal and Infant Outcomes Following Exposure to SPIKEVAX During Pregnancy
Lead sponsor
ModernaTX, Inc.
Phase
Observational
Overall status
Completed
Start date
March 1, 2023
Completion date
October 20, 2023
Enrollment
1,192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infant outcomes, maternal outcomes, pregnancy